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Lipid rafts are operationally defined as cholesterol-rich membrane microdomains 
resistant to solubilization in nonionic detergents at low temperatures. Lipid rafts, which 
are quite different in lipid composition from the surrounding membranes, are of great 
importance to signal transduction, protein sorting and membrane transport. They have 
been implicated in a range of biosynthetic and endocytic processes and systems-signaling, 
molecular trafficking, diseases as well as being involved in the immune, vascular, 
digestive and reproductive systems. Dietary nutrients like fatty acids and vitamins of 
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Section One: Structures and properties of lipid rafts 
 
Introduction 
Lipid rafts are microdomains with different lipid components than the adjacent 
membranes (1). They are liquid-ordered domains that are more tightly packed than the 
surrounding non-raft phase of the bilayer. The tighter packing results from a higher 
cholesterol content and a greater concentration of saturated hydrocarbon chains in raft 
sphingolipids and phospholipids, unlike the unsaturated fatty acids of phospholipids in 
the non-raft phase (2). The cholesterol-rich domains on cellular membranes are of great 
importance to signal transduction, protein sorting and membrane transport (3). Enriched 
with glycosphingolipids, sphingomyelin and cholesterol, lipid rafts are resistant to 
solubilization with non-ionic detergents because of the sphingolipid assemblies which are 
stabilized by addition of cholesterol. Therefore, we can take advantage of their 
insolubility in various concentrations of non-ionic detergents to isolate the components of 
lipid rafts.  
A fundamental characteristic of lipid rafts is their ability to prevent undesirable 
protein-protein interactions, such as those that occur in disrupted signal transduction, 
because they can distinguish different proteins at the membranes (1). Specific protein-
protein interactions such as the activation of signaling pathways involve a series of 
proteins which alter the sizes and compositions of lipid rafts when cells are subject to an 
intra- or extra-cellular signal. Such protein-protein interactions can be realized due to 
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another important property of lipid rafts that they can include or exclude proteins to 
variable extents.  
Although lipid rafts are most abundant at the plasma membrane, they are also found 
in the biosynthetic and endocytic organelles. Cholesterol-sphingolipid rafts are first 
produced in the Golgi before moving towards the plasma membrane (4). Then they are 
endocytosed successively from cell surfaces (5). Rafts either recycle back from 
endosomes to the surface or return indirectly through recycling endosomes (6). 
 
Characteristics of detergent-resistant membrane domains 
The reason why non-ionic detergents can be applied in the extraction of lipid rafts is 
related with the chemical compositions and physical features of rafts. Lipid rafts are 
enriched with sphingolipid and cholesterol. They have very long saturated acyl chains 
and high acyl chain melting temperature, which makes it possible for raft domains to be 
resistant to detergents. Early research (7) showed that a sphingolipid and cholesterol-rich 
raft could be isolated by the property of its insolubility in non-ionic detergent of Trition 
X-100, which suggests that tight interactions between sphingolipid and cholesterol might 
help to form lipid microdomains because they are probably associated with any 
detergent-resistant proteins in cells. Sphingolipids are much more resistant to 
solubilization than phospholipids while cholesterol is also detergent-resistant in the 
microdomains where sphingolipids are located. In particular, insolubility might be due to 
glycosphingolipid lipid clusters. Later on, scientists found that glycosyl 
phosphatidylinositol (GPI) anchored proteins tend to gather in detergent-resistant 
membrane (DRM) domains, which provides supportive evidence for the idea that 
 2
membrane proteins might become detergent-insoluble when they interact with lipid rafts 
(8).    
A few proteins bind to saturated-chain lipids, which are probably necessary to insert 
into tightly packed membrane domains. This fact provides a hypothesis that such acyl 
chains may play an important role in the targeting of these proteins. The proteins of this 
type first recognized are those anchored by GPI. It is necessary to have the GPI-anchor 
when these proteins bind to DRMs. Moreover, GPI-anchored proteins generally have 
saturated acyl chains, which proves that they are related to ordered domains.  Particularly, 
they are likely to interact with lipids that can be detergent-insoluble and stabilize them in 
ordered microdomains. 
Though early evidence (9) found that the insoluble material extracted from cells may 
be made up of a certain protein associated with some kind of lipids, yet detergent 
insolubility also exists even without any protein, which further indicates the existence of 
lipid-lipid interactions mentioned above. One research study shows that the high-melting 
temperature, saturated-chain phospholipid dipalmitoyl phosphatidylcholine is Triton 
insoluble in liposomes, while the low-melting temperature, unsaturated-chain 
phospholipid dioleoyl phosphatidylcholine is solubilized from the same liposomes (10). 
This result is probably associated with the insolubility by the tight packing ability and 
unusually high melting temperature of sphingolipids. This property of sphingolipids 
indicates that detergent-resistant phase enriched in tightly packed sphingolipids might be 
separated from a phase enriched in loosely packed phospholipids. One research paper 
reports a similar result showing that pure dipalmitoyl phosphatidylcholine is insoluble in 
Triton X-100 when it exists in the gel phase (11). 
 3
Isolation of lipid rafts is accomplished, using non-ionic detergents, such as Triton X-
100 and Brij (12). Since the upper limit of the solubility of Brij at 4℃ is 0.5%, while rafts 
are usually prepared using Triton X-100 of 1% concentration, the two detergent 
concentrations are applied here. When either of the traditional detergents for isolation is 
applied, the cell membrane will dissolve but such a detergent cannot destroy the 
structures of the lipid rafts which, therefore, can be extracted. These detergent-resistant 
remnants of the lipid rafts have been referred to as DRMs, which are supposed to be 
subsets of the endogenous lipid rafts. 
Non-ionic detergent is quite important for extraction of lipid raft fractions. The 
detergent gathers smaller lipid rafts into larger microdomains, which allows them to form 
bilayer vesicles (13). It shows that the function of such a detergent in the membrane is to 
motivate liquid-ordered microdomains to aggregate in number and size under certain 
conditions, usually at low temperatures. That is why the environmental condition of 4℃ 
has been chosen for this experiment. A recent study (14) reports that under detergent-free 
circumstances, there is no obvious separation into high and low density fractions which 
come from membrane vesicles isolated from the cell. Moreover, only a light fraction is 
obtained, resembling lipid rafts. The two detergents mentioned above have different 
chemical structures, which result in different molecular properties of raft microdomains 
isolated by these two types of detergents. In particular, the orientation of the extracted 
rafts seems to be associated with the detergent used (15). It is reported that lipid rafts 
isolated using Brij tend to form low-density vesicles of right-side-out orientation while 
those extracted using Triton X-100 appear to form high-density vesicles of inside-out 
vesicles. These two detergents can thus be used to extract lipid rafts whose properties are 
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different in orientation, density and protein composition. Therefore, it makes sense to 
consider that the two detergents are capable of extracting different subsets of lipid rafts, 
indicating that they may be associated with the physicochemical characteristics of the 
isolated lipid rafts. It is likely that the structures of the detergents may determine to which 
extent the membranes could be inverted by adjusting the orientation and size of the 
gathered lipid rafts when the forming of vesicles is in process. 
A recent study (16) that looks into the application of different detergents in preparing 
raft domains has found that these detergents are able to isolate lipid rafts due to the 
difference in their selectivity. For instance, Triton X-100 is a kind of highly-selective 
detergent, which is used to destroy protein-lipid interactions so as to extract rafts subsets 
that have low protein contents. In comparison, Tween 20, which is a typical low-
selectivity detergent, is only able to extract raft subsets that have much higher protein 
contents. On the other hand, in spite of the fact that a highly-selective detergent is 
favored in terms of DRM fraction preparation, a weaker detergent, such as Brij, could 
also be a good candidate for raft isolation because it does not tend to disrupt the original 
protein-lipid interactions in the raft domains to such an extent as a highly-selective 
detergent. The application of a highly-selective detergent, like Triton X-100, appears to 
dissolve too many raft fractions, which might lead to the misunderstanding of the 
association between these fractions and the whole raft domains. 
From the viewpoint of regarding lipid rafts as a heterogeneous collection of 
microdomains with different features in biophysics and biochemistry (15), we can also 
explain why the two detergents mentioned above are capable of extracting lipid rafts with 
different density or protein contents. As is known, lipid rafts are highly-dynamic 
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structures, which suggests that different fractions in them are exchanging from time to 
time. Therefore, Triton X-100 and Brij are likely to disrupt protein-lipid interactions to 
produce distinct fractions of raft domains.  
 
Arguments concerning the existence of rafts in cell membranes 
Since single rafts are too small to resolve, a key unanswered question is whether rafts 
exist in cell membranes. In other words, it is argued whether membranes have discrete 
microdomains in liquid-ordered phase or liquid-crystalline phase. A recent study shows 
that discrete liquid-crystalline phase microdomains could float in a liquid-ordered sea, 
which was found in sphingolipid-rich membranes (17). Meanwhile, DRMs are also found 
in cell membranes where lipid rafts exist in a detergent-soluble liquid-crystalline phase 
sea. In spite of the fact that liposomes are partially detergent-insoluble due to high levels 
of sphingolipid and cholesterol, the proposal that lipid rafts are present in cell membranes 
cannot be proved by partial detergent insolubility because membranes in a single uniform 
phase that has an intermediate property between the liquid-ordered phase and liquid-
crystalline phase could also show the characteristic of partial insolubility. Therefore, lipid 
rafts might gather in a regulated way despite the fact that they do not exist constitutively. 
When it comes to the interactions between proteins and lipids, there is a new 
perspective of the question of whether rafts exist. For instance, GPI-anchored proteins 
and glycosphingolipids have a high affinity for an ordered environment. Thus, once they 
exist in cell membranes, they tend to gather and form a raft microdomain, which can be 
used as a morphological marker. Many proteins and lipids have similar properties 
mentioned above, which contributes to the formation of visible lipid rafts. However, 
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these lipid rafts present in membranes are very difficult to observe because GPI-anchored 
proteins are located uniformly in cell membranes while glycosphingolipids do not appear 
in a larger cluster than a few molecules (18).  
Fortunately, the clusters of certain proteins and lipids in plasma membranes have 
been found to support the proposal that lipid rafts really exist. A recent typical case is the 
IgE receptor in immune cells. Another example is some certain proteins which tend to 
gather in an ordered environment of DRMs, such as some GPI-anchored proteins and 
some transmembrane proteins. These proteins are capable of co-gathering when they are 
clustered independently, which suggests that they are present in rafts. 
Although lipid rafts are considered to be dynamic structures that are estimated to be 
small when they are not activated, yet they may cluster together to generate much larger 
domains once receptor-ligand binding occurs. In other words, if the small raft 
components are crosslinked with antibodies or lectins, lipid fractions and raft protein will 
tend to aggregate while raft and non-raft components tend to be divided into micron-sized 
patches (19). The number of proteins in each raft depends on the packing density, which 
is less than 10 – 30 proteins. In spite of its small size, a lipid raft still contains a subset of 
all the raft proteins, which indicates that raft aggregation could activate raft signaling to a 
great extent. No sooner does ligand binding occur than receptors move into raft domains. 
As an example, scientists have observed the formation of an immunological synapse 
which is a specific link between T cells and antigen-presenting cells (20). But how these 
structures are associated with rafts has not been understood clearly though raft fractions 
play an important role in immunological synapses. 
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Relation between caveolae and lipid rafts  
In comparison with classical lipid rafts which are short of structural protein 
components, liquid-ordered domains may have a specific structural protein component, 
which tends to alter the features of lipid rafts in both appearance and function. In 
particular, as the structural component of caveolin-1 is inserted into a lipid raft, these 
microdomains invaginate and form caveolae. This new structure is flask-shaped with its 
location at or near the plasma membrane. A recent report (21) investigates vesicular 
trafficking events and signal transduction processes involving caveolins which function 
as scaffolding proteins to gather and organize particular lipid-modified signaling 
molecules within caveolae membrane. Another study (22) reports that the binding of 
caveolins with liquid-ordered domains appears to initiate the biogenesis of caveolae in 
the Golgi. It is proposed that lipid rafts can be considered to be precursors of caveolae 
that assist caveolins to participate in membranes.  
Caveolins can generate a heterooligomeric complex in cells (21). As the functional 
assembly units of caveolae, these caveolin heterooligomers interact with cholesterol. 
Since the caveolin gene family is quite conserved from worms to humans, caveolins are 
very important in adjusting lipid raft function. Moreover, caveolins also modulate some 
signaling proteins, such as oncogenes. The interaction of caveolins with signaling 
proteins regulates their activation state, which suggests that adjusting the expression of 
caveolins could affect signaling pathways. It is known to all that caveolae are associated 
with cholesterol and that caveolin-1 tends to bind cholesterol. The loss of caveolae from 
the plasma membrane is attributed to the absence of cellular cholesterol. Therefore, 
caveolins also appear to play a significant part in the regulation and transport of 
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cholesterol levels in lipid rafts (23). In other words, signaling pathways may be affected 
by the regulation of caveolin expression. 
In summary, classical lipid rafts contain glycosphingolipids, cholesterol, lipid-
modified proteins with saturated acyl chains as well as transmembrane proteins. They are 
in liquid-ordered phase and are 50 nanometres in diameter. In contrast, the components of 
caveolae are mainly raft proteins, lipids and caveolins. They have morphological “cave-



















Section Two: Methods of studying lipid rafts 
 
Introduction to different methods of investigating lipid rafts 
The primary method of studying lipid rafts is based on the resistance of lipid rafts to 
extraction by Triton X-100 at 4℃(24). However, these DRM fractions are aggregates of 
raft domains, and thus, do not represent the native state of lipid rafts in cell membranes. 
In addition, antibodies or lectins can be used to crosslink with raft components in 
living cells so that lipid rafts are grouped (25). As a result, these patches may be detected 
by standard light microscopy. Otherwise, single rafts are too small to resolve, which leads 
to the opinion that rafts are likely not to exist in cells.  
The pilot application of single fluorescent molecule microscopy to living cells makes 
it possible to detect the membrane domains in a direct fashion (12). With a lipid probe of 
saturated acyl chains combined to these domains, the fluorescence microscopy can catch  
the images of single molecules through lipid probes in their motional path (single dye 
tracing, SDT). Since SDT renders it possible to track single lipid probe molecules in vivo 
and to follow their motion within a millisecond, such a novel method has been employed 
to search for lipid microdomains or rafts in the plasma membrane that is rich in certain 
probe molecules. 
Another method of visualizing membrane lipid structure of living cells is the usage of 
two-photon microscopy, in which living cells are labeled with the fluorescent probe, 
Laurdan, which is an environmentally sensitive fluorescence probe. Due to any 
environmental stimulation, Laurdan will release red shifts at different wavelengths into 
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lipid rafts within the membranes in their natural state. A study compared the properties of 
microscopically visible domains with those of isolated DRMs, and thereby, providing 
strong support for the lipid raft hypothesis (3). 
In fluorescence microscopy and in molecular biology, fluorescence resonance energy 
transfer (FRET) is a useful tool to find out how proteins interact with other molecules or 
how conformational changes occur in them. Therefore, FRET can be employed to detect 
whether two raft components are spatially close. For monitoring the complex formation 
between them, for example, one of them is modified with a donor and the other with an 
acceptor before these fluorophore-labeled molecules are blended. When they are 
separated, the donor excitation will lead to the donor emission which can be observed 
through fluorescence microscopy. In contrast, when the distance between the donor and 
the acceptor is less than 10 nm because of the interaction of the two components, the 
transfer of FRET from the donor and the acceptor will result in the apparent detection of 
the acceptor emission (26). 
 
Protocols 
1. Cell Lysis 
1) Wash 300mg cells (~107 cells) twice in PBS and add 2.7ml TNE to the pellet.  
2) Disrupt cells with 15 strokes in a homogenator. 
3) Transfer extracts to a micro centrifuge tube and spin at 15,000 rpm at 4℃; discard 
the pellet.  
4) Recover the supernatant; spin the supernatant at 100,000x g for one hour and re-
suspend the pellet in 450μl ice-cold 1xTNE-T (1xTNE containing 1% Triton X-100).  
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2. Sucrose Density Gradient Preparation 
1) Prepare three 50 ml tubes labeled as follows: 13.75%, 22.5%, 31.25%.  
2) Add 20 ml of 5% Sucrose and 20 ml of 40% Sucrose to the tube labeled 22.5%.  
3) Add 10 ml of 5% Sucrose and 10 ml of 22.5% Sucrose to the tube labeled 13.75%.  
4) Add 10 ml of 40% Sucrose and 10 ml of 22.5% Sucrose to the tube labeled 31.25%.  
5) Add the following Sucrose solutions sequentially in Beckman SW55 Ti rotor tubes: 
Use a large bore pipette tip (cut off approximately 2 mm from the tip of a 1 ml pipette 
tip) and "layer" the solutions very slowly into the tube. 
   950 μl of 40% Sucrose 
   950 μl of 31.25% Sucrose 
   950 μl of 22.5% Sucrose 
   950 μl of 13.75% Sucrose 
   950 μl of 5% Sucrose  
6) Gently keep the tube of Sucrose solution layers at 4°C for at least 12 to 16 hr (i.e., 
overnight). A linear gradient will form.  
3. Isolation of lipid rafts from total cell lysates 
1) Layer the crude cellular extract on top of the Sucrose gradient solution.  
2) Insert the tube into a pre-chilled SW55 Ti rotor at 4°C. Balance the rotor with 
another tube of equal mass and centrifuge the Sucrose gradient at 4°C for 4 hr at 
50,000 rpm (approximately 237,000x g).  
3) After centrifugation, prepare sixteen microcentrifuge tubes on ice. Remove the 
centrifuge tube from the rotor and place on ice. 
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4) Carefully transfer 300 μl of fractions from the top of the gradient to the 
microcentrifuge tubes with large-bore pipette tips.  
5) Assay the fractions by SDS-PAGE; run Western immunoblot analysis. 
4. Hints 
1) Every solution must be ice-cold and procedures are performed on ice. 
2) If it is difficult to get the pellet in TNE-T into solution, it is appropriate to sonicate 
it for a few seconds. 
3) When recovering the supernatant, make sure that the pellet is intact. 
4) In terms of preparing different concentrations of sucrose, the buffer will be the 
same composition as the extract to be fractionated by centrifugation. The presence of 
sucrose or glycerol in the starting extract will also affect the migration of proteins.  
5) When layering the solution very slowly into the tube, it is useful to prop the 
centrifuge tube in a bucket of ice and tilt the tube to approximately 30° to assist in the 
gentle layering of each Sucrose solution on top of the previous solution. If the 
layering is not gentle enough, the fractionation will be smeary. While layering, notice 
the barely visible layers of solution.  
6) Be careful not to overload the gradient with too much protein when layering the 
crude cellular extract on top of the Sucrose gradient solution. This requires empirical 






Results and discussion 
Lipid rafts are isolated using extraction with cold 1% Triton X-100, followed by 
sucrose density sedimentation. A raft marker called the GPI-anchored GM1 ganglioside 
is used in Western immunoblot analysis in order to locate the raft-containing fractions.  
Figure 1 shows the results from the experiment where 5 μl antibodies are added into 
the fractions with the incubation time of 24 hours. Roughly speaking, the blot has a high 
background, and thus, no specific proteins could be observed. In the control experiment 
(Figure 2), 2.5 μl antibodies are added into the fractions with the incubation time of 12 
hours. Rafts are visible between the 5% and the 30% interface. In particular, from Lane 
15 and 16, specific proteins could be observed, which indicates the extraction of lipid 
rafts. Moreover, the whole proteins from cell lysis are also used to run Western 
immunoblot analysis for further references (Figure 3). 
In terms of the high background in Figure 1, there might be a couple of reasons. First 
of all, blocking of non-specific binding might be insufficient. In this case, the blocking 
incubation period could be increased and another blocking agent may be chosen as a 
better candidate. Secondly, cross-reactivity between blocking agents and antibodies will 
lead to an overall membrane staining. Under most circumstances, the addition of a mild 
detergent to the incubation and washing buffers will eliminate such a problem. Thirdly, 
the concentration of antibody is probably too high or the incubation time might be too 
long. The higher the antibody concentration and the longer the incubation time is, the 
greater the likelihood for non-specific staining is. Fourthly, membranes tend to dry out 
during the incubation process. Finally, washing of unbound antibodies may be 
insufficient. So the number of washes may be increased. 
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In Figure 2, similar problems occur with regard to high backgrounds, which could be 
solved according to the discussion above. Besides, a smile effect of the bands is observed. 
This is probably due to fast or hot migration, which could be altered by changing the pH 
or slowing down the migration or running the gel on ice. Furthermore, uneven white 
spots exist on the blot, which is attributed to air bubbles trapped against the membrane 
during transfer or antibodies which are not evenly spread on the membrane. In order to 



















Section Three: Lipid rafts in immune cells 
 
The lipid rafts at the cell surface may contribute to signal transduction. In a lipid raft, 
single receptors may be activated by ligand binding and then cluster together on 
concentration platforms on which non-raft enzymes such as membrane phosphatases will 
not be able to exert a negative influence on the signaling complex (25). By grouping 
together, individual rafts are able to connect different proteins and form a signaling 
complex. A typical example is the combination of doubly acylated non-receptor tyrosine 
kinases and G proteins from separate rafts.  
In the models for signal initiation in lipid rafts, signaling occurs in either single rafts 
or clustered rafts. In single rafts, ligand binding crosslink with receptors in living cells so 
that these receptors are ready for further activation and signaling. In clustered rafts, raft 
coalescence may come into being when crosslinking proteins in different rafts are 
combined together through activated receptors. Both of these models may function at the 
same time to lead to an even larger network of interactions among different proteins that 
will be involved in the whole signaling process. As mentioned above, lipid rafts have a 
liquid-ordered phase that prevents signaling complexes from such negative factors as 
non-raft enzymes in the surrounding liquid-disordered phase. After that, the complete 
signaling pathway is activated by the concentration of a series of clustered rafts which 
can include or exclude proteins according to the initial stimulations. 
Researchers have recognized the presence and importance of lipid rafts in cellular 
signaling by comparing the initial signaling processes within lipid rafts and the situations 
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with the disruption of lipid rafts (25). If the cholesterol from the membrane is removed 
from lipid rafts, there will be negative changes in cellular function due to the disruption 
of the lipid rafts. 
The B cell receptor (BCR) tends to move into a lipid raft domain when B cells come 
up with an antigen. Then it produces a signal to make the cell transform into plasma cells 
which can release antibodies accordingly. However, when lipid rafts are deprived of 
cholesterols in B lymphocytes, the BCRs tend to lose their ability to produce the signal so 
that antibodies are formed. 
A recent model describes the initial steps that lead to phosphorylation of T cell 
receptors (TCRs) in lipid rafts. Within T cells in a resting status, the TCRs seem not to 
incorporate with lipid rafts very frequently. However, antigen presentation by antigen-
presenting cells (APCs) helps to associate the TCRs with lipid rafts. Similar to what 
happens to the BCRs, the TCRs will no longer release signals due to antigen attachment 
when rafts are extracted from T lymphocytes. 
Furthermore, lipid rafts seem to be involved in another important signaling system of 
the EGF-receptor family, EGFR (Epidermal Growth Factor Receptor). A study suggests 
that the EGFR is more likely to accept its donor, together with cholesterol when it is 
tested in artificial membranes. That is why high-affinity EGFR exists in the domains with 
adequate cholesterol (27). In conclusion, lipid rafts have been implicated in a huge range 
of other processes and systems-signaling, molecular trafficking, diseases such as HIV and 





Section Four: Dietary effects on lipid rafts 
 
Fatty acids 
Dietary n-3 polyunsaturated fatty acids (PUFAs) are beneficial in preventing various 
diseases, such as autoimmune and inflammatory diseases, coronary heart disease, 
diabetes, and cancer. PUFAs may change T cell functional responses and the effects of 
PUFAs on T cells might be due to lipid raft disruption. 
A large number of studies have investigated the role of long-chain (n-3) PUFA 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) which could be 
associated with the inhibition of tumor growth (28-30). Generally speaking, the 
mechanism for the growth-inhibitory effects of PUFAs on cancer cells is associated with 
their interactions in membrane phospholipids of tumor cells. Particularly, the PUFAs 
change the composition of plasma membranes where signaling pathways occur so that 
they may help to inhibit the growth of cancer cells.  
In a recent study (31), cells were prepared in a medium with long-chain PUFAs, 
eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA). Originally, the DRMs had 
a higher concentration of saturated fatty acids and a lower concentration of PUFAs, EPA 
and DHA than membrane phospholipids. After the incubation with EPA and DHA, the 
composition of DRMs was changed in such a way that there was less sphinogomyelin and 
cholesterol and more phosphatidycholine. Such a change in the composition of lipids may 
be attributed to the movement of lipids between DRMs and any other membranes. 
Alternatively, it may also be due to the hydrolysis process of lipids in DRMs. In the paper 
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mentioned above, it reported that neutral sphinogomyelinase activity was enhanced by 
EPA and DHA. Meanwhile, more ceramides were generated within the DRMs of the 
cells treated with EPA and DHA. Since sphingomyelin hydrolysis generated ceramide 
that took part in the process of apoptosis, the change in lipid composition which induced 
the increase of neutral sphinogomyelinase activity might be the reason why PUFAs could 
exert inhibitory effects on the growth of cancer cells. Therefore, long-chain PUFAs may 
alter the types of lipids in raft microdomains as well as the composition of fatty acids, 
which would further change raft functions. However, it is controversial that the function 
of ceramide is always linked to its potency to induce cell death, because the dynamic 
balance between cellular levels of ceramide and other sphingolipids can regulate 
opposing signaling pathways. For example, low concentrations of ceramide could 
promote T-cell activation through the up-regulation of expression of TCRs, while higher 
concentrations of ceramide might induce cell death so as to terminate T-cell responses. 
On the other hand, the concentration of epidermal growth factor (EGF) receptors in 
DRMs decreased after the treatment of EPA and DHA, while the number of 
phosphorylated EGF receptors was increased by PUFAs. In fact, the phosphorylation 
process of EGF receptor occurred after they migrated out of rafts. In addition, loss of 
cholesterol resulted in depletion of EGF receptor from lipid rafts and promoted its 
binding to EGF and phosphorylation, which produced further proapoptotic signals. 
Finally, the processes mentioned above led to cell apoptosis, reducing tumor cells. 
Not only does dietary fatty acid composition tend to alter lipid compositions and 
structures within DRMs, but also is associated with some transcription factors which can 
regulate expression of caveolin, such as peroxisome proliferator-activated receptor-γ and 
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sterol regulatory element binding protein (SREBP) (32). Peroxisome proliferator-
activated receptor-γ is likely to increase expression of caveolin while SREBP may 
manipulate cell membrane composition and regulate lipid synthesis (33). One of the best 
examples involved in intracellular signaling is sterol carrier protein (SCP)-2, which has 
very high affinity for binding and can shuttle many types of lipids in a very selective 
manner. SCP-2 is also known to be capable of distributing signaling lipids between 
intracellular sites and lipid rafts (34). These recent studies proposes that SCP-2 plays a 
key role in cholesterol and phospholipid transfer as well as in manipulating a number of 
transcription-related lipid signaling pathways in raft microdomains of cell membranes. 
Furthermore, PUFAs can help to ameliorate aging-related disease, such as brain 
ischemia and Alzheimer’s disease. For instance, DHA, which is enriched in neuronal 
membranes, participates in membrane activation and translocation processes by 
esterifying with phosphatidylserine at raft microdomains. In this way, DHA could 
provide a binding site for transcriptional factors so as to down-regulate apoptotic 
caspases (35). That is why DHA are able to promote the growth of neurons and the 
development of brains. This result also supports the clinical finding that neurological 
deficits probably result from the deficiency of n-3 fatty acids.  
 
Cholesterol 
Located among the hydrocarbon chains of sphingolipids, cholesterol serves as a 
dynamic link that clusters lipid raft microdomains (36). Cholesterol is known to have 
higher affinity to raft sphingolipids than to unsaturated phospholipids, serving as a spacer 
between the raft phase and the nonraft phase. Experimental results also show that despite 
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the insolubility property of raft-linked lipids and proteins, raft proteins tend to become 
detergent-soluble when cholesterol is isolated by methyl-β-cyclodextrin or saponin (37). 
Therefore, loss of raft cholesterol could make most proteins separated from lipid rafts, 
and subsequently, these proteins lose their normal functions.  
Scientists have found that lipid rafts are first assembled in the Golgi complex (36). 
Particularly, cholesterol is synthesized in the endoplasmic reticulum (ER). Its synthesis 
process is very similar to that of ceramide, which is known as the hydrophobic backbone 
of sphingolipids. In the Golgi complex, most of the sphingolipid head groups are linked 
with ceramide. A recent study has found that the content of cholesterol and sphingolipids 
increases from the ER to the plasma membrane because lipid rafts are not allowed to go 
back and forth between the ER and the Golgi complex (38). That is why lipid rafts can 
only travel from the Golgi complex to the plasma membrane, where they aggregate and 
take part in many important signaling pathways. The supply of lipid rafts to cell 
membranes is strictly manipulated by cholesterol and sphingolipid concentrations within 
the Golgi complex. 
On the other hand, it is important to know that cholesterol is harmful, to some extent. 
Therefore, its concentrations in cells should be tightly limited and regulated in several 
ways. For example, a complicated system of transcriptional regulation is set up to 
monitor the biosynthesis and cellular uptake of cholesterol. In addition, cholesterol may 
be deposited into fat droplets in an esterified form. If these regulation processes are 
disrupted for some reason, a lot of serious aging diseases related with lipid metabolism 
will come into being, such as Alzheimer’s disease. Broadly speaking, the mechanism of 
such diseases involves dysregulation of cholesterol metabolism and accumulation of 
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cholesterol in metabolic overload, which is associated with high levels of triglyceride and 
low levels of high-density lipoprotein in different aging-related diseases. High-fat diets 
including saturated fat and red meat contain large amounts of cholesterol, which exerts 
negative influence on such diseases as type 2 diabetes, obesity and vascular diseases. 
Moreover, the dynamics and composition of lipid membranes are highly sensitive to any 
disorders in cholesterol metabolism. One example is that people are at higher risk for 
developing Alzheimer’s disease when the plasma cholesterol levels in their bodies are 
found to increase. Recent researches show that removal of cholesterol from cells helps to 
inhibit the synthesis process of a certain transmembrane protein called APP (39). It is 
also observed that the patients who are treated chronically with cholesterol synthesis 
inhibitors are likely to have far less risk for developing Alzheimer’s disease. The 
mechanism involved is discussed in detail in the following section. 
 
Vitamins 
An increased concentration of end products of lipid peroxidation is the evidence most 
frequently quoted for the involvement of free radicals in human disease (40). Lipid 
peroxidation is initiated by the attack on a fatty acid or fatty acyl side chain of any 
chemical species that has sufficient reactivity to abstract a hydrogen atom from a 
methylene carbon in the side chain. The occurrence of lipid peroxidation in biological 
membranes causes impairment of membrane functioning, changes in fluidity, inactivation 
of membrane-bound receptors and enzymes, and increased nonspecific permeability to 
ions. For example, deformation of red blood cells after exposure to peroxides causes 
them to become leaky to potassium ions. It is also noticed that antioxidant nutrients are 
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able to interact with lipid membrane microdomains and down-regulate signaling 
pathways involving inflammatory responses and atherosclerosis so as to protect vascular 
endothelium from environment toxicity.  
Evidence predominantly from in vitro studies suggests that antioxidant vitamins can 
prevent or mitigate lipid peroxidation (41). Vitamin C protects bio-membranes against 
peroxidative damage in the aqueous phase. Vitamin E is considered to be the 
predominant lipid-soluble, chain-breaking micronutrient antioxidant. Some studies 
suggest that vitamin C may enhance the effects of vitamin E by reducing tocopheroxyl 
radicals, which means that vitamin C and vitamin E have synergistic effects. 
Besides, a significant inverse linear correlation between malondialdehyde levels and 
natural antioxidant levels was recorded (42). Lipid peroxidation products are significantly 
increased in groups of subjects with deficient levels of vitamin C, vitamin E and both 
vitamins, if compared to group with normal vitamin levels. The results show that the 
deficiency in two key antioxidants for lipid peroxidation inhibition means the insufficient 
defense against free radicals and the increased lipid peroxidation. 
Furthermore, scientists have investigated Carboxyethyl-hydroxychromans (CEHC), 
hydrosoluble vitamin E metabolites, which are excreted through the renal filter (43). 
Because of the highest levels of CEHC in hemodialysis (HD) patients, it makes sense to 
look into CEHC accumulation which may affect patients’ plasma antioxidant status. It is 
obvious that in these patients there is a significant impairment of the non-enzymatic 
antioxidant network. In addition, increased antioxidant consumption by sustained 
oxidative stress has been proposed to occur in these patients. With the dialysis-dependent 
 23

























Section Five: Lipid raft-associated diseases 
 
Insulin resistance and type 2 diabetes 
In contrast to type 1 diabetes that lack sufficient insulin in bodies, type 2 diabetes are 
associated with decreased ability of cells or tissues to react to normal levels of insulin, 
which is called insulin resistance (44). Scientists have proposed that lipid rafts might 
serve as a critical platform where insulin signaling is compartmentalized to function in 
adipocytes (45). As a family of sialic acid-containing glycosphingolipids, gangliosides 
tend to play a structurally and functionally important role in raft microdomains. One 
recent paper reports that the most abundant ganglioside is called GM3, which is over-
expressed when the level of TNF-α increases in adipocytes (46).  
TNF-α is known to induce dedifferentiation of adipocytes and reduce gene expression 
on components of insulin receptor signal transduction pathway, such as GLUT4 genes 
and IRS-1 (47). Particularly, TNF-α triggers a moderate decrease of insulin-induced 
phosphorylation of insulin receptors, leading to a more prominent inhibition of insulin-
stimulated phosphorylation of IRS-1 without any impacts on the expression of either 
insulin receptors or IRS-1. Since many studies have proved that TNF-α is a critical 
component involved in insulin resistance (48, 49), it is intriguing to investigate the 
relationship between TNF-α and GM3 so as to demonstrate the mechanism of insulin 
resistance in type 2 diabetes.  
One pioneer approach is to test obese-diabetic mice in which the GM3 synthase 
mRNA levels in adipose tissues are significantly higher than in controls (50). In the 
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experiment, an inhibitor of glucosylceramide synthase called D-PDMP was used so as to 
clarify whether the elevated level of GM3 contributed to the inhibition of insulin-
dependent insulin receptor internalization as well as the removal of insulin receptors from 
lipid raft membranes treated with TNF-α. As was expected, the dissociation of insulin 
receptors from raft microdomains was partially blocked while the internalization of 
insulin receptors was effectively suppressed after GM3 depletion by D-PDMP. When 
treated with TNF-α, the level of GM3 increased by nearly 100% within DRMs in contrast 
to the results in normal adipocytes. Additionally, a recent study reports that mice in short 
of GM3 synthase tend to exhibit enhanced insulin signaling (51). These findings are 
consistent with the results from another research paper which examines the effect of 
TNF-α on the function and composition of DRMs and concludes that the loss of insulin 
receptors from raft domain membranes is probably attributed to elevated level of GM3. 
Subsequently, it induces the inhibition of insulin’s metabolic signaling (50). In other 
words, GM3 depletion may become a potential target for mitigating the TNF-α-induced 
inhibition of insulin receptor accumulation in lipid raft microdomains when it comes to 
the future treatment of insulin metabolic signaling defect in insulin resistance. 
 
Alzheimer’s disease 
Lipid rafts are involved in Alzheimer’s disease, known for regulating protein 
processing and signaling (52). Formation of senile plaques containing the amyloid-β-
peptide is a hallmark of this disease. Amyloid-β-peptide is derived by proteolytic 
cleavage from the amyloid precursor protein called APP by β-secretase and γ-secretase. It 
has been shown that lipid membrane microdomains as well as caveolae provide a critical 
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platform where APP is processed to be different kinds of β-amyloid peptides (53). 
Although the mechanism of Alzheimer’s disease is not well-known yet, researchers 
suggest that it is a key point to investigate in depth how APP processing is regulated 
within lipid raft microdomains. It is found that β-amyloid peptide production is somehow 
dependent on the integrity of lipid raft microdomains while lower levels of cholesterol 
help decrease β-amyloid peptide production (53). 
When it comes to processing of APP to form its intracellular domain, a lipid 
membrane microdomain associated protein called Flotillin-1 plays an important role as an 
APP intracellular domain interacting protein (54). With the help of Flotillin-1, APP may 
be guided towards lipid raft microdomains. Therefore, Flotillin-1 is regarded as a 
participant in the processing and localization of APP. Another study also supports this 
proposal, reporting that there is a positive correlation between the concentration of 
Flotillin-1 and the progression of Alzheimer’s disease (55).  
In addition to Flotillin-1, cholesterol also takes an active part in regulating different 
cleavage processes of APP. Apolipoprotein E is known as a major apolipoprotein in the 
brain, serving as a carrier to deliver cholesterol within central nervous system. It exerts 
significant influence on compositions of lipid microdomain and properties of enzymes, 
transport proteins and receptors that mediate β-amyloid peptide production and 
degradation (56). Besides, there is a positive correlation between the concentration of β-
amyloid peptide in the brains of Alzheimer’s disease patients and levels of total low-
density lipoprotein and cholesterol in serum. One clinical study has found that the 
increase in cholesterol level during mid-life is likely to elevate the risk of developing 
Alzheimer’s disease (57). Furthermore, removal of cholesterol is shown to inhibit the 
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formation of β-amyloid peptides in neurons by shifting the partitioning of APP from lipid 
rafts to surrounding lipid bilayer. Since β-amyloid peptides are derived from APP 
cleaved by a certain enzyme called β-secretase, the existence of APP and β-secretase 
together is very likely to increase the production of β-amyloid peptides. However, 
considering that cell surface rafts are very small and contain only a subset of proteins, 
APP is less likely to meet with β-secretase in the same rafts. Therefore, the formation of 
β-amyloid peptides is supposed to be limited on cell membranes. Conversely, the 
production of β-amyloid peptides is strongly stimulated after antibody cross-linking 
which is attributed to clustering of a large number of surface rafts where APP and β-
secretase co-exist. 
Even after processing of APP, certain interactions between lipid rafts and β-amyloid 
peptides are likely to have impacts on the development of Alzheimer’s disease. A number 
of recent studies have shown such an important role of lipid rafts in β-amyloid peptides 
production. For example, raft binding may result in a conformational change that triggers 
amyloid plaque formation (58). Another result shows that the ganglioside GM1, known 
as one raft component, tends to bind β-amyloid peptides and probably alter their 
conformation, too. 
 
Age-Related Macular Degeneration 
Age-Related Macular Degeneration (AMD) is the major cause of vision loss in 
elderly people. The percentage of older people is increasing rapidly among the whole 
population, especially in developed regions and countries, while the people at 65 and 
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older tend to suffer much more from this disease. Therefore, AMD is becoming an 
important clinical problem and an attractive research topic. 
Oxidative stress is believed to be one of the mechanisms behind the development of 
AMD. It is a biological process where cellular damage is caused by reactive oxygen 
intermediates (ROI), which is related with many diseases, especially age-related disorders. 
ROIs include free radicals, singlet oxygen, and hydrogen peroxide, which are usually the 
byproducts of oxygen metabolism. Generally speaking, cumulative oxidative damage is 
responsible for aging and paid great attention to in the pathogenesis of AMD. 
The retina is particularly susceptible to oxidative stress because of a large amount of 
polyunsaturated fatty acids present within lipid raft domains (59). A characteristic of 
retinal lipids is that the photoreceptor membranes of both rods and cones contain a lipid 
bilayer that have very high proportion of long-chain PUFAs found in all phospholipid 
classes. These PUFAs are quite susceptible to oxidation since they have a number of 
double bonds. Therefore, the retina is correspondingly susceptible to lipid peroxidation 
which may lead to loss of membrane function and structural integrity (60). There is also 
evidence that the ability to present an anti-oxidant defense at the macula diminishes with 
increasing age. 
In order to reduce oxidative damage, many researchers have investigated the effects 
of nutritional antioxidant supplements on the onset and natural course of AMD (61). 
Although the relationships between dietary and serum levels of antioxidants and AMD 
are less clear yet, people believe that such nutrients as vitamins, PUFA, lutein, zeaxanthin 
and zinc may help lower the risk of AMD or slow down the progression of dry macular 
degeneration. 
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Investigations have shown that diet poor in vitamin A, C and E and low plasma levels 
of antioxidants tend to lead to the development of AMD, which indicates that this 
supplementation enhances antioxidant defense and might prevent or retard AMD (62). As 
is mentioned above, these anti-oxidant vitamins are able to react directly and non-
enzymatically with ROIs, generating harmless products and terminating free radical chain 
reactions. Also, the retina contains high levels of these vitamins in rod outer segments 
and RPE, and the concentrations within these tissues are very sensitive to dietary intake 
of them (63). Therefore, the consequences are consistent with previous studies which 
have shown that photochemical retinal injury is due to oxidative stress and that the 
antioxidant vitamins A, C, and E protect against this type of injury. 
What is more, many scientists have been focusing on a supplementation of long-chain 
PUFA of the n-3 family, which is known as DHA, as it addresses primary prevention of 
AMD (60). A supplementation of n-3 PUFAs could be proposed to certain subjects at risk 
for AMD for primary prevention. 
Furthermore, high plasma levels of lutein and zeaxanthin are associated with reduced 
risk of neovascular AMD (64). It is known that lutein and zeaxanthin are two major 
components in macular pigments which serve to filter blue light, and thus, protect against 
this possible source of photooxidative damage to the neurosensory retina. Lutein and 
zeaxanthin accumulate in the eye lens and macular region of the retina and their 
concentrations in the macula are greater than those found in plasma and other tissues. 
Because of their very high absorptivity, lutein and zeaxanthin in the inner retina form a 
very efficient filter for blue-light that reaches the back of the eye. This reduction in blue-
light intensity could significantly reduce the oxidative stress on the retina, and therefore, 
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contribute to the reduction in risk of AMD, which is shown in many recent researches (64, 
65). That is why higher dietary intake of lutein and/or zeaxanthin is associated with 
decreased likelihood of having large or extensive intermediate drusen and neovascular 
AMD. 
In addition, zinc is the most abundant trace element in the human eye. It acts as a 
cofactor for CuZn-SOD and is involved in the regulation of catalase activity. Therefore, 
zinc is a key component in antioxidant defenses (66). Also, it induces the synthesis of 
metallothionein, which functions in clearing hydroxyl radicals, and stabilizes membrane 

















Section Six: Summary 
 
Recent studies show that lipid rafts can be isolated from cells with non-ionic 
detergents as extraction agents. It indicates that such sphingolipid and cholesterol-rich 
membranes appear to exist and are involved in signal transduction through GPI-anchored 
proteins as well as high-affinity receptors. Lipid rafts also play a critical role in 
trafficking and sorting through endocytic and secretory pathways, which is involved in 
diverse immune processes related with aging. Rafts have a close relationship with 
diabetes, different types of cancers, Alzheimer’s disease, and many other aging-related 
diseases. Therefore, the properties of rafts can be used in treatment or prevention of any 
of these diseases in future. In addition, the investigation of dietary nutrients, such as fatty 
acids and vitamins, tend to become an important topic because of their participation in 
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